KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Consolidated Net Income: 2010-2015

Historic Consolidated Net Income for Biocryst Pharmaceuticals (BCRX) over the last 4 years, with Sep 2015 value amounting to -$14.3 million.

  • Biocryst Pharmaceuticals' Consolidated Net Income fell 11.36% to -$14.3 million in Q3 2015 from the same period last year, while for Sep 2015 it was -$42.2 million, marking a year-over-year decrease of 0.88%. This contributed to the annual value of -$50.7 million for FY2014, which is 43.14% down from last year.
  • Biocryst Pharmaceuticals' Consolidated Net Income amounted to -$14.3 million in Q3 2015, which was down 443.67% from $4.2 million recorded in Q2 2015.
  • In the past 5 years, Biocryst Pharmaceuticals' Consolidated Net Income ranged from a high of $4.2 million in Q2 2015 and a low of -$16.4 million during Q4 2014.
  • For the 3-year period, Biocryst Pharmaceuticals' Consolidated Net Income averaged around -$10.2 million, with its median value being -$12.8 million (2014).
  • In the last 5 years, Biocryst Pharmaceuticals' Consolidated Net Income tumbled by 117.43% in 2014 and then skyrocketed by 132.37% in 2015.
  • Quarterly analysis of 5 years shows Biocryst Pharmaceuticals' Consolidated Net Income stood at -$12.1 million in 2011, then grew by 3.47% to -$11.3 million in 2012, then dropped by 17.79% to -$7.6 million in 2013, then plummeted by 117.43% to -$16.4 million in 2014, then dropped by 11.36% to -$14.3 million in 2015.
  • Its Consolidated Net Income stands at -$14.3 million for Q3 2015, versus $4.2 million for Q2 2015 and -$15.6 million for Q1 2015.